Epperly Melissa B,

CIK 00018073594 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001807359

Recent Transactions

50 trades

Award
Roivant Sciences Ltd.$ROIV
Common Shares
2026-01-20+815→ 57,719 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2026-01-20$22.98/sh−54→ 57,665 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-20+1,056→ 56,904 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-09-10+14,524→ 57,509 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-09-10$13.77/sh−1,661→ 55,848 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-09-10+33,726→ 33,726 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-07-17+1,609→ 42,985 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2025-06-23+45,000→ 45,000 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-04-17+1,847→ 41,376 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2025-01-23$11.21/sh−180→ 39,529 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-01-23+1,672→ 39,709 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-10-21+1,613→ 38,037 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-12$12.12/sh−4,245→ 36,424 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-09-10+27,894→ 27,894 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-10+16,406→ 40,669 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-07-23+1,702→ 24,263 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2024-06-14+45,000→ 45,000 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-04-24+1,146→ 22,684 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-04-24$10.90/sh−123→ 22,561 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−25,000→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−60,751→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-12$11.44/sh−2,573→ 451,449 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-02$11.54/sh−8,669→ 454,022 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-01+75,000→ 462,691 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2024-02-01+75,000→ 75,000 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-01-19+1,207→ 21,538 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2023-10-16+1,226→ 20,331 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-10-04$19.91/sh−888→ 387,691 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-10-04$19.43/sh−4,594→ 388,579 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-12+17,825→ 19,105 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2023-09-12+26,595→ 26,595 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2023-07-03+1,280→ 1,280 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2023-06-15+45,000→ 45,000 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2023-06-12+25,000→ 25,000 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-14$19.98/sh−5,227→ 392,048 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-13$20.42/sh−2,624→ 397,275 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2023-02-01+148,043→ 148,043 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-01+101,957→ 399,899 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-10-03+50,000→ 297,543 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2022-07-20+186,916→ 186,916 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2022-06-15+86,467→ 86,467 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2022-06-13+20,250→ 20,250 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-04-04$48.75/sh−8,094→ 256,400 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-04-04$49.90/sh−1,303→ 255,097 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-04-04$51.99/sh−4,512→ 247,767 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-04-04$50.70/sh−2,818→ 252,279 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-04-04$52.44/sh−353→ 247,414 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-02-23$48.81/sh−1,211→ 265,196 total

Companies

Recent Filings

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, X0, SW1H 0DB

View on SEC.gov